Canada's largest fertility network sells US clinic to IVI RMA
What's the deal? The Fertility Partners (TFP), Canada's largest network of fertility clinics, has sold Illume FertilityDealroom has a profile for this one. Try Dealroom → to IVI RMA North AmericaDealroom has a profile for this one. Try Dealroom →. The transaction closed on September 3, 2026. Illume serves patients across Connecticut and New York.
What each side does: TFP brings together fertility clinics and IVF laboratories across Canada. IVI RMADealroom has a profile for this one. Try Dealroom → North America is part of IVI RMA GlobalDealroom has a profile for this one. Try Dealroom →, which employs more than 5,000 people across over 200 locations in 15 countries.
Why now? TFP is calling the sale a deliberate portfolio decision, one that frees up capital and leadership attention for growth in its home market. Illume has joined IVI RMA's US network of clinics, laboratories, and reproductive medicine providers.
What's the endgame? TFP wants to build the leading fertility network in Canada. It says it will keep investing in the infrastructure and technology that strengthen access and improve clinical outcomes.
"For TFP, this is about focus," said chief executive officer Heather Stark. "Our strongest opportunities are here in Canada, and this transaction allows us to put our full attention on building the leading fertility network in the country."
What changes for patients? TFP, Illume, and IVI RMA worked together during closing to support continuity for patients, physicians, employees, and partners. Illume will continue offering IVF, fertility preservation, and third-party reproduction under IVI RMA.
The signal: The deal reflects consolidation in reproductive medicine, with global players like IVI RMA expanding US footprints while regional networks concentrate on home markets. For TFP, retreating from the US sharpens its bet on Canadian fertility care.
Image credit: Generated with Gemini
